ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,738Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 459

$376K Total Retail Price of All Prescriptions

Rank: 39 out of 459

298 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,312 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 488 406 1 6
SIMVASTATIN 403 325 2 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 293 181 3 21
HYDROCHLOROTHIAZIDE 279 237 4 9
METOPROLOL SUCCINATE 244 221 5 27
OMEPRAZOLE 234 183 6 3
FUROSEMIDE 210 201 7 8
METFORMIN HCL 192 179 8 7
LISINOPRIL 191 143 9 4
LEVOTHYROXINE SODIUM 178 153 10 5
ATORVASTATIN CALCIUM 153 136 11 15
ATENOLOL 128 101 12 14
DIOVAN HCT 116 97 13 72
CARVEDILOL 111 93 14 23
LOSARTAN POTASSIUM 109 97 15 22
GABAPENTIN 105 100 16 10
METFORMIN HCL ER 102 79 17 43
POTASSIUM CHLORIDE 99 75 18 24
WARFARIN SODIUM 92 79 19 17
AMLODIPINE BESYLATE-BENAZEPRIL 90 85 20 95
SERTRALINE HCL 85 63 21 20
FLUTICASONE PROPIONATE 84 32 22 36
ALLOPURINOL 82 71 23 52
LOSARTAN-HYDROCHLOROTHIAZIDE 82 58 23 49
DILTIAZEM 24HR CD 79 68 25 150
PRAVASTATIN SODIUM 78 65 26 12
NEXIUM 77 30 27 16
NIFEDIPINE ER 74 70 28 139
CRESTOR 65 65 29 31
DIOVAN 63 60 30 59
NAMENDA 61 61 31 106
CLONIDINE HCL 61 48 31 60
GLIPIZIDE XL 61 52 31 130
METOPROLOL TARTRATE 58 58 34 11
ADVAIR DISKUS 56 43 35 53
PROAIR HFA 54 42 36 32
GLIMEPIRIDE 51 45 37 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.